ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Åõ¿© °æ·Îº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032
»óǰÄÚµå : 1424052
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 117 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,889,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,275,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,661,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 85¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

õ½Ä, ·ù¸¶Æ¼½º °üÀý¿°, ÇǺΠÁúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ±ÞÁõÀº ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀåÀÇ ±âȸ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å´Â °­·ÂÇÑ Ç׿°Áõ È¿°ú·Î ÀÎÇØ ÀÌ·¯ÇÑ ÁúȯÀÇ °ü¸®¿¡ ÇʼöÀûÀ̸ç, Àü ¼¼°èÀûÀ¸·Î ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ýȰ½À°ü ¿äÀο¡ ÈûÀÔ¾î È¿°úÀûÀÎ Ç׿°Áõ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵尡 ÃÖÀü¼±¿¡ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. Á¦¾à Çõ½ÅÀº ¸Å¿ì Áß¿äÇϸç, ±â¾÷Àº ƯÁ¤ ¸¸¼º Áúȯ¿¡ ´ëÇÑ ¸ÂÃãÇü Á¦Á¦¸¦ °³¹ßÇÏ¿© ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå¿¡¼­ Áõ°¡Çϴ ǥÀû Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀåÀº »ý¹°ÇÐÀû Á¦Á¦¿Í º´¿ë¿ä¹ýÀÇ ÀáÀçÀû ÅëÇÕÀ¸·Î ÀÎÇÑ ±âȸ¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Ç¥Àû ¸ÞÄ¿´ÏÁòÀ» °¡Áø »ý¹°ÇÐÀû Á¦Á¦´Â ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÇ ±¤¹üÀ§ÇÑ Ç׿°Áõ ÀÛ¿ë°ú ½Ã³ÊÁö È¿°ú¸¦ ¹ßÈÖÇÏ¿© Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ºÎÀÛ¿ëÀ» ÁÙÀÌ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÚ°¡¸é¿ªÁúȯ°ú ¿°Áõ¼º ÁúȯÀÇ ¿ªµ¿ÀûÀÎ »óȲ¿¡¼­ ´Ù¾çÇÑ Ä¡·á¹ýÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ƯÁ¤ °æ·Î¿¡ ÀÛ¿ëÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦´Â ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Ä¡·á¿¡ °³ÀÎÈ­µÈ Â÷¿øÀ» Ãß°¡ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû Á¶ÇÕÀº »õ·Î¿î Á¦Á¦ ¹× Ä¡·á ¿ä¹ýÀÇ °³¹ßÀ» ÃËÁøÇÏ°í º¹ÀâÇÑ º´Å»ý¸®¸¦ °ü¸®Çϱâ À§ÇÑ º¸´Ù È¿°úÀûÀÌ°í ¸ÂÃãÈ­µÈ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå¿¡ Á¡ÁøÀûÀÎ º¯È­¸¦ °¡Á®¿À°í Ä¡·á È¿°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý ÀÇ·á¿Í ÀüÀÚ °Ç°­Àº ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀåÀ» Çü¼ºÇÏ´Â µ¥ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ¸¸ç »õ·Î¿î ±âȸ¸¦ ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ÀÇ·áÀÇ µðÁöÅÐÈ­´Â ¿ø°Ý ÁøÂûÀ» °¡´ÉÇÏ°Ô Çϰí ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å ó¹æ¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô Çß½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇϰí ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ¿ä¹ýÀ» Àû½Ã¿¡ Á¶Á¤ÇÒ ¼ö ÀÖ´Â ±ÇÇÑÀ» ºÎ¿©ÇÕ´Ï´Ù.

EÇコ ¼Ö·ç¼ÇÀº Á¤º¸ È帧À» °£¼ÒÈ­Çϰí ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÇ »ç¿ë¹ý°ú ºÎÀÛ¿ë¿¡ ´ëÇÑ È¯ÀÚ ±³À°À» °­È­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µðÁöÅÐ ÅëÇÕÀº ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Ä¡·áÀÇ º¸±ÞÀ» È®´ëÇÒ ¼ö ÀÖÀ¸¸ç, ƯÈ÷ ÀÇ·á ¼­ºñ½º¸¦ Á¦´ë·Î ¹ÞÁö ¸øÇϴ ȯÀڵ鿡°Ô ÇýÅÃÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀåÀº ¿ø°Ý ÀÇ·á°¡ Á¦°øÇÏ´Â Æí¸®ÇÔ°ú È¿À²¼ºÀ» Ȱ¿ëÇÏ¿© ȯÀÚ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ» ÃËÁøÇϰí Çõ½Å, µ¥ÀÌÅÍ ±â¹Ý ÀλçÀÌÆ®, ÀÇ·á ¼­ºñ½º Á¢±Ù¼º °­È­ÀÇ ±æÀ» ¿­¾îÁÙ °ÍÀÔ´Ï´Ù.

ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2023³â ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀÌµå ºÎ¹®Àº ¹ü¿ë¼º, ¸¸¼º Áúȯ °ü¸® ¹× Ä¡·áÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â¿¡´Â Àü½Å Èí¼ö ¾ïÁ¦, ±¹¼Ò Ä¡·á, ´Ù¸¥ Ä¡·á¹ý°úÀÇ È£È¯¼ºÀ¸·Î ÀÎÇØ ±¹¼Ò ºÎ¹®ÀÌ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â ÇǺΠ¾Ë·¹¸£±â ºÎ¹®Àº Ç׿°Áõ Ư¼º, ºü¸¥ Áõ»ó ¿ÏÈ­ ¹× ±¤¹üÀ§ÇÑ ÀÀ¿ë ºÐ¾ß·Î ÀÎÇØ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â, ºÏ¹Ì Áö¿ªÀÌ ±âÁ¸ ±â¾÷, ±ÔÁ¦ ȯ°æ, Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü ¹× ¿¬±¸ °³¹ß·Î ÀÎÇØ ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Sanofi S.A. µî ¼¼°è ½ÃÀå ÁøÃâ ±â¾÷ÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ ½ÃÀå °æÀïÀÌ Ä¡¿­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå, Åõ¿© °æ·Îº°

Á¦6Àå ¼¼°èÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå, À¯Çüº°

Á¦7Àå ¼¼°èÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå, ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï »óȲ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Corticosteroids market size is expected to reach USD 8.53 billion by 2032, according to a new study by Polaris Market Research. The report "Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surging prevalence of chronic diseases such as asthma, rheumatoid arthritis, and dermatological disorders propels opportunities in the corticosteroids market. Vital for managing these conditions due to their potent anti-inflammatory properties, corticosteroids witness rising demand globally. Fueled by lifestyle factors, the demand for effective anti-inflammatory solutions positions corticosteroids at the forefront. Pharmaceutical innovation becomes crucial, presenting companies with the prospect of developing tailored formulations for specific chronic diseases, meeting the growing need for targeted therapeutic solutions in the corticosteroids market.

The corticosteroids market is capitalizing on opportunities presented by the potential integration of biologics and combination therapies. Biologics, with targeted mechanisms, synergize with the broad anti-inflammatory actions of corticosteroids, aiming for enhanced therapeutic outcomes and reduced side effects. In the dynamic landscape of autoimmune and inflammatory disorders, diversified treatment modalities are crucial. Biologics, addressing specific pathways, add a personalized dimension to corticosteroid treatments. This strategic combination fosters the development of novel formulations and treatment regimens, offering more effective and tailored solutions for managing complex conditions, marking a progressive shift in the corticosteroids market and promising improved therapeutic efficacy.

Telemedicine and E-Health are increasingly pivotal in shaping the corticosteroids market, opening novel opportunities. The digital transformation in healthcare allows for remote consultations, facilitating easier access to corticosteroid prescriptions. These platforms empower healthcare providers to monitor patients, ensuring timely adjustments to corticosteroid regimens.

E-Health solutions streamline information flow, enhancing patient education on corticosteroid usage and side effects. This digital integration not only boosts patient adherence but also broadens the reach of corticosteroid therapies, particularly benefiting underserved populations. The corticosteroids market capitalizes on the convenience and efficiency introduced by telemedicine, fostering a patient-centric approach and creating avenues for innovation, data-driven insights, and enhanced healthcare accessibility.

Corticosteroids Market Report Highlights

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

Polaris Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Corticosteroids, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Corticosteroids, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Corticosteroids Market Insights

5. Global Corticosteroids Market, by Route of Administration

6. Global Corticosteroids Market, by Type

7. Global Corticosteroids Market, by Application

8. Global Corticosteroids Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â